Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Lydia R. Meador"'
Autor:
Arpan Deb, William A Johnson, Alexander P Kline, Boston J Scott, Lydia R Meador, Dustin Srinivas, Jose M Martin-Garcia, Katerina Dörner, Chad R Borges, Rajeev Misra, Brenda G Hogue, Petra Fromme, Tsafrir S Mor
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0172529 (2017)
Viral protein U (Vpu) is a type-III integral membrane protein encoded by Human Immunodeficiency Virus-1 (HIV- 1). It is expressed in infected host cells and plays several roles in viral progeny escape from infected cells, including down-regulation of
Externí odkaz:
https://doaj.org/article/b4bf8b971cc542fbb57eb2ed80c4af4c
Autor:
Sarah A Kessans, Mark D Linhart, Lydia R Meador, Jacquelyn Kilbourne, Brenda G Hogue, Petra Fromme, Nobuyuki Matoba, Tsafrir S Mor
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151842 (2016)
It is widely anticipated that a prophylactic vaccine may be needed to control the HIV/AIDS epidemic worldwide. Despite over two decades of research, a vaccine against HIV-1 remains elusive, although a recent clinical trial has shown promising results
Externí odkaz:
https://doaj.org/article/f4351c501c2b4ea6bbd95c4fc6a17706
Autor:
K. Taraszka Hastings, Todd C. Metzger, Lydia R. Meador, Matthew Rausch, Handong Li, Shenfeng Qiu, Mark S. Anderson
Publikováno v:
J Immunol
Journal of immunology (Baltimore, Md. : 1950), vol 204, iss 11
Journal of immunology (Baltimore, Md. : 1950), vol 204, iss 11
Central tolerance prevents autoimmunity, but also limits T cell responses to potentially immunodominant tumor epitopes with limited expression in healthy tissues. In peripheral APCs, γ-IFN–inducible lysosomal thiol reductase (GILT) is critical for
Autor:
Andrew G. Diamos, Tsafrir S. Mor, Hugh S. Mason, Qiang Chen, Jacquelyn Kilbourne, Mary D. Pardhe, Haiyan Sun, Lydia R. Meador, Joseph G. L. Hunter
Publikováno v:
Vaccine
Zika virus (ZIKV) reemergence poses a significant health threat especially due to its risks to fetal development, necessitating safe and effective vaccines that can protect pregnant women. Zika envelope domain III (ZE3) has been identified as a safe
Autor:
Karen Hastings, Matthew P. Rausch, Lydia R. Meador, Todd C. Metzger, Handong Li, Shenfeng Qiu, Mark S Anderson
Publikováno v:
The Journal of Immunology. 204:217.4-217.4
Central tolerance prevents autoimmunity, but also limits T cell responses to potentially immunodominant tumor epitopes with limited expression in healthy tissues. In peripheral antigen presenting cells (APCs), gamma-interferon-inducible lysosomal thi
Autor:
Giuseppe Pantaleo, Tsafrir S. Mor, Joseph N. Blattman, Karen V. Kibler, Mariano Esteban Roderiguez, Lydia R. Meador, Jacquelyn Kilbourne, Bertram L. Jacobs, Sarah A. Kessans
Publikováno v:
Virology, vol. 507, pp. 242-256
Showing modest efficacy, the RV144 HIV-1 vaccine clinical trial utilized a non-replicating canarypox viral vector and a soluble gp120 protein boost. Here we built upon the RV144 strategy by developing a novel combination of a replicating, but highly-
Publikováno v:
Encyclopedia of Signaling Molecules ISBN: 9781461464389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d407a90769f91392309647848eba4b
https://doi.org/10.1007/978-1-4614-6438-9_101662-1
https://doi.org/10.1007/978-1-4614-6438-9_101662-1
Autor:
Nobuyuki Matoba, Brenda G. Hogue, Jacquelyn Kilbourne, Sarah A. Kessans, Petra Fromme, Tsafrir S. Mor, Mark D. Linhart, Lydia R. Meador
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151842 (2016)
PLoS ONE
PLoS ONE
It is widely anticipated that a prophylactic vaccine may be needed to control the HIV/AIDS epidemic worldwide. Despite over two decades of research, a vaccine against HIV-1 remains elusive, although a recent clinical trial has shown promising results
Autor:
Tsafrir S. Mor, Braeden Schaefer, Rachael W. Sirianni, Apisara Ausvasomrit, Thanchanok Boonsompong, Rebecca L. Cook, Lydia R. Meador, Joseph N. Blattman
Publikováno v:
Neuro-Oncology. 18:vi97-vi98
Autor:
Tsafrir S. Mor, Lydia R Meador
The VLPNPV 2014 Conference that was convened at the Salk institute was the second conference of its kind to focus on advances in production, purification, and delivery of virus-like particles (VLPs) and nanoparticles. Many exciting developments were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a98e83f66e5ad823df47be007ac6af8
https://europepmc.org/articles/PMC5443066/
https://europepmc.org/articles/PMC5443066/